Guangxi Chisage Fine Chemical Technology Co., Ltd.
000953.SZ · SHZ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 160.61M | 11.30M | -101.48M | -100.44M | -0.27 |
| 2023 FY | 187.50M | 20.57M | -12.31M | -11.56M | -0.03 |
| 2024 FY | 211.52M | 29.95M | 94.45M | 79.25M | 0.22 |
| 2025 FY | 179.68M | 30.95M | 7.08M | 6.53M | 0.02 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 286.71M | 192.26M | 56.25M | 5.00M | 77.84M |
| 2023 FY | 281.23M | 198.33M | 64.63M | 144.13M | 66.60M |
| 2024 FY | 332.94M | 171.08M | 89.24M | 123.38M | 145.04M |
| 2025 FY | 265.97M | 95.22M | 55.91M | 46.54M | 153.11M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 799.52K | -33.01M | -32.21M | -141.50K | 20.56M |
| 2023 FY | 20.93M | -12.36M | 8.57M | -171.45K | 8.38M |
| 2024 FY | -28.04M | -16.36M | -44.40M | -164.59K | 24.61M |
| 2025 FY | 51.93M | -7.52M | 44.41M | — | -33.33M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2023 FY | 2.15B | 2.23B | — | — | — |
| 2024 FY | 2.01B | 2.05B | — | — | — |
| 2025 FY | 2.64B | 2.63B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 40.00M | 6.26M | 2.85M | 2.48M | 0.01 |
| 2025 Q3 | 48.62M | 11.09M | 4.21M | 4.10M | 0.01 |
| 2025 Q4 | 50.23M | 7.60M | -1.44M | -1.41M | 0.00 |
| 2026 Q1 | 37.23M | 5.72M | 1.55M | 953.63K | 0.00 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 284.34M | 117.49M | 59.10M | 67.68M | 149.60M |
| 2025 Q3 | 272.12M | 100.36M | 46.60M | — | 154.14M |
| 2025 Q4 | 265.97M | 95.22M | 55.91M | 46.54M | 153.11M |
| 2026 Q1 | 272.22M | 100.06M | 58.68M | — | 154.36M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 20.42M | -277.62K | 20.14M | — | 20.19M |
| 2025 Q3 | 12.29M | -2.11M | 10.19M | — | -12.51M |
| 2025 Q4 | 9.20M | -4.79M | 4.41M | — | 9.31M |
| 2026 Q1 | 4.21M | -1.30M | 2.91M | — | 2.78M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 2.51B | 2.52B | — | — | — |
| 2025 Q3 | 2.65B | 2.61B | — | — | — |
| 2025 Q4 | 2.64B | 2.63B | — | — | — |
| 2026 Q1 | 2.57B | 2.51B | — | — | — |